Literature DB >> 12593737

Detection and estimation of avian infectious bronchitis virus antigen by a novel indirect liquid-phase blocking enzyme-linked immunosorbent assay using chicken and rabbit affinity purified immunoglobulins.

Natalia N Lougovskaia1, Andrei A Lougovskoi, Yuri A Bochkov, Galina V Batchenko, Natalia S Mudrak, Vladimir V Drygin, Alexander V Borisov, Vladimir V Borisov, Anatoly A Gusev.   

Abstract

An indirect liquid-phase blocking (LPB) enzyme-linked immunosorbent assay (ELISA) using chicken and rabbit affinity purified immunoglobulin G (IgG) has been developed to detect and estimate avian infectious bronchitis virus (IBV) antigen concentration directly in infected allantoic fluid. The method is based on the principle of binding of specific IgG to the test IBV antigen and the assay of unbound IgG on an antigen-coated ELISA plate. The immunoglobulins are chicken N-terminal S2 peplomeric protein-specific IgG isolated by immunoaffinity chromatography on synthetic peptide coupled to CNBr-activated Sepharose 4B or rabbit polyclonal IgG purified from the serum using Protein A Sepharose 4B. The assay detected all tested IBV strains and field isolates propagated in chicken embryos. Signal to noise ratios were calculated from LPB ELISA absorbance units and a diagnostic threshold was established from the signal to noise ratio frequency distribution of samples positive or negative for IBV by virus titration or reverse transcription polymerase chain reaction. The relative sensitivity of the test ranged between 10(5) and 10(6) median egg infectious doses (EID(50)) for chicken IgG and between 10(3) and 10(4) EID(50) for rabbit IgG, depending on the test strain. The assay is simple and takes less than 3 h to perform. It does not require expensive reagents and can be readily adapted to monitor the IBV antigen concentration in allantoic fluids during propagation of vaccine strains or in samples of freeze-dried, live-attenuated IBV vaccines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12593737     DOI: 10.1080/0307945021000024571

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  6 in total

1.  Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines.

Authors:  Yang Zang; Dongchuan Du; Peng Ge; Yongqing Xu; Xintao Liu; Yan Zhang; Weiheng Su; Irina Kiseleva; Larisa Rudenko; Fei Xu; Wei Kong; Chunlai Jiang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  A Novel Immunochromatographic Strip for Antigen Detection of Avian Infectious Bronchitis Virus.

Authors:  I-Li Liu; Yi-Chun Lin; Yong-Chong Lin; Cai-Zhen Jian; Ivan-Chen Cheng; Hui-Wen Chen
Journal:  Int J Mol Sci       Date:  2019-05-06       Impact factor: 5.923

3.  Analysis of the complete genomic sequences of two virus subpopulations of the Australian infectious bronchitis virus vaccine VicS.

Authors:  José A Quinteros; Philip F Markham; Sang-Won Lee; Kylie A Hewson; Carol A Hartley; Alistair R Legione; Mauricio J C Coppo; Paola K Vaz; Glenn F Browning
Journal:  Avian Pathol       Date:  2015-04-01       Impact factor: 3.378

4.  Detection of antibodies to avian infectious bronchitis virus by a recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay.

Authors:  N N Lugovskaya; A V Scherbakov; A S Yakovleva; M A Tsyvanyuk; N S Mudrak; V V Drygin; A V Borisov
Journal:  J Virol Methods       Date:  2006-05-03       Impact factor: 2.014

5.  Phylogenetic analysis of partial S1 and N gene sequences of infectious bronchitis virus isolates from Italy revealed genetic diversity and recombination.

Authors:  Yury A Bochkov; Giovanni Tosi; Paola Massi; Vladimir V Drygin
Journal:  Virus Genes       Date:  2006-10-17       Impact factor: 2.332

6.  Full genome analysis of Australian infectious bronchitis viruses suggests frequent recombination events between vaccine strains and multiple phylogenetically distant avian coronaviruses of unknown origin.

Authors:  José A Quinteros; Sang-Won Lee; Philip F Markham; Amir H Noormohammadi; Carol A Hartley; Alistair R Legione; Mauricio J C Coppo; Paola K Vaz; Glenn F Browning
Journal:  Vet Microbiol       Date:  2016-11-06       Impact factor: 3.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.